Nanobiotix Issues Statement Regarding Recent Media Speculation Concerning Intentions For A Potential Public Takeover; Says There Is No Such Intention To Acquire Control Of The Company, And No Process Or Assessment Is Being Conducted Toward That End

NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, today issued the following statement in response to recent media speculation concerning intentions for a potential public take-over.

Nanobiotix states that, to the best of its knowledge, there is no such intention to acquire control of the Company, and no process or assessment is being conducted toward that end. Additionally, the Company has identified factual inaccuracies in this media report which are not consistent with the Company's most recent public disclosures.